Eyenovia, Inc. (EYEN)
Largest Insider Buys in Sector
EYEN Stock Price History Chart
EYEN Stock Performance
About Eyenovia, Inc.
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for …
Insider Activity of Eyenovia, Inc.
Over the last 12 months, insiders at Eyenovia, Inc. have bought $1.23M and sold $0 worth of Eyenovia, Inc. stock.
On average, over the past 5 years, insiders at Eyenovia, Inc. have bought $3.09M and sold $1.27M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Grant Stuart M. (10 percent owner) — $1.18M. Rowe Michael M (Chief Executive Officer) — $49,227.
The last purchase of 27,071 shares for transaction amount of $14,077 was made by Rowe Michael M (Chief Executive Officer) on 2024‑08‑28.
List of Insider Buy and Sell Transactions, Eyenovia, Inc.
| 2024-08-28 | Chief Executive Officer | 27,071 0.0354% | $0.52 | $14,077 | -1.64% | |||
| 2024-08-26 | Chief Executive Officer | 50,000 0.0699% | $0.57 | $28,500 | -4.12% | |||
| 2024-07-02 | 10 percent owner | 1.52M 2.9465% | $0.66 | $1,000,000 | 0.00% | |||
| 2024-03-28 | 10 percent owner | 100,000 0.2097% | $0.98 | $98,000 | -35.01% | |||
| 2024-03-19 | 10 percent owner | 50,000 0.1186% | $1.23 | $61,500 | -44.89% | |||
| 2024-03-08 | 10 percent owner | 10,717 0.0243% | $1.58 | $16,911 | -56.52% | |||
| 2023-12-04 | Chief Executive Officer | 4,890 0.011% | $1.36 | $6,650 | -35.80% | |||
| 2023-09-29 | director | 4,820 0.0128% | $1.68 | $8,098 | -26.66% | |||
| 2023-09-19 | Chief Executive Officer | 1,400 0.0036% | $1.66 | $2,324 | -23.08% | |||
| 2023-09-15 | Chief Executive Officer | 1,137 0.003% | $1.75 | $1,990 | -24.71% | |||
| 2023-08-17 | 10 percent owner | 30,000 0.082% | $1.87 | $56,100 | -21.86% | |||
| 2023-08-16 | 10 percent owner | 45,000 0.1195% | $1.91 | $85,815 | -24.07% | |||
| 2023-05-31 | Chief Financial Officer | 2,000 0.0053% | $2.79 | $5,580 | -41.02% | |||
| 2023-05-26 | director | 3,000 0.0077% | $2.49 | $7,470 | -34.75% | |||
| 2023-05-26 | Chief Operating Officer | 2,500 0.007% | $2.73 | $6,825 | -34.75% | |||
| 2023-05-25 | 10 percent owner | 88,247 0.2531% | $2.65 | $233,855 | -31.38% | |||
| 2023-05-23 | director | 10,000 0.027% | $3.10 | $30,976 | -44.63% | |||
| 2023-05-15 | director | 4,000 0.011% | $3.39 | $13,560 | -47.80% | |||
| 2023-05-01 | Sale | director | 90,000 0.2501% | $5.50 | $495,000 | -66.65% | ||
| 2023-04-27 | Sale | director | 60,000 0.1604% | $5.00 | $300,000 | -64.60% |
Insider Historical Profitability
| Grant Stuart M. | 10 percent owner | 10914153 12.7592% | $0.50 | 44 | 0 | <0.0001% |
| Rowe Michael M | Chief Executive Officer | 109998 0.1286% | $0.50 | 12 | 0 | <0.0001% |
| Yoshida Shuhei | 1718566 2.0091% | $0.50 | 1 | 0 | <0.0001% | |
| Senju Pharmaceutical Co., Ltd. | 10 percent owner | 1718566 2.0091% | $0.50 | 1 | 0 | <0.0001% |
| ESHELMAN FREDRIC N | 1273428 1.4887% | $0.50 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $1.77M | 3.26 | 1.79M | +25.25% | +$355,870.86 | <0.0001 | |
| BlackRock | $1.55M | 2.87 | 1.58M | -3.62% | -$58,346.47 | <0.0001 | |
| Cowen Group | $816,261.00 | 1.51 | 827,851 | New | +$816,261.00 | 0.03 | |
| Geode Capital Management | $683,715.00 | 1.26 | 693,343 | +8.49% | +$53,519.35 | <0.0001 | |
| State Street | $512,012.00 | 0.95 | 519,282 | +6.37% | +$30,664.60 | <0.0001 |